Mohammed Rassool to Phosphodiesterase 4 Inhibitors
This is a "connection" page, showing publications Mohammed Rassool has written about Phosphodiesterase 4 Inhibitors.
Connection Strength
0,187
-
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med. 2021 08; 9(8):897-908.
Score: 0,187
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.